university website

M. Paul (Mical), Y. Carmeli (Yehuda), G.L. Daikos (George), E. Durante-Mangoni (Emanuele), U. Theuretzbacher (Ursula), J.W. Mouton (Johan) and L. Leibovici (Leonard)

2018-05-01

Colistin versus colistin plus meropenem for severe infections: Authors' reply

Publication

Publication

The Lancet Infectious Diseases , Volume 18 - Issue 5 p. 495- 496

We appreciate Daniele Giacobbe’s Correspondence regarding the importance of colistin minimum inhibitory concentrations.
A study showed that both gradient-based and semi-automated devices can overestimate susceptibility to colistin. [...]

Additional Metadata
Persistent URL doi.org/10.1016/S1473-3099(18)30223-8, hdl.handle.net/1765/105899
Journal The Lancet Infectious Diseases
Organisation Department of Medical Microbiology and Infectious Diseases
Citation
Paul, M, Carmeli, Y, Daikos, G.L, Durante-Mangoni, E, Theuretzbacher, U, Mouton, J.W, & Leibovici, L. (2018). Colistin versus colistin plus meropenem for severe infections: Authors' reply. The Lancet Infectious Diseases, 18(5), 495–496. doi:10.1016/S1473-3099(18)30223-8

See Also
article
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria
M. Paul (Mical), G.L. Daikos (George), E. Durante-Mangoni (Emanuele), Yahav, D. (Dafna), Y. Carmeli (Yehuda), Benattar, Y.D. (Yael Dishon), Skiada, A. (Anna), Andini, R. (Roberto), Eliakim-Raz, N. (Noa), Nutman, A. (Amir), et al. Zusman, O. (Oren), A. Antoniadou (A.), Pafundi, P.C. (Pia Clara), Adler, A. (Amos), Dickstein, Y. (Yaakov), Pavleas, I. (Ioannis), Zampino, R. (Rosa), Daitch, V. (Vered), Bitterman, R. (Roni), Zayyad, H. (Hiba), Koppel, F. (Fidi), Levi, I. (Inbar), Babich, T. (Tanya), L.E. Friberg (Lena), J.W. Mouton (Johan), U. Theuretzbacher (Ursula) and L. Leibovici (Leonard)


User Publication Person Organisation Collection
Close